FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/104765 [Registered on: 25/02/2026] Trial Registered Prospectively
Last Modified On: 24/02/2026
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Prospective Observational Study 
Study Design  Single Arm Study 
Public Title of Study   What Happens When Blood Flow Is Restored During Liver Transplant Surgery : How It Affects the New Liver and Patient Recovery 
Scientific Title of Study   Post Reperfusion Syndrome In Living Donor Liver Transplantation: Incidence, Predictors, and Impact on Early Allograft Dysfunction and Patient Outcomes 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Eshita Singh 
Designation  Anaesthesiologist 
Affiliation  Medanta The Medicity Hospital, Gurugram 
Address  Department of Liver Transplant and GI Anaesthesia, Medanta The Medicity Hospital, Gurugram 122001

Gurgaon
HARYANA
122001
India 
Phone  9902145542  
Fax    
Email  hanakoeshi07@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Eshita Singh 
Designation  Anaesthesiologist 
Affiliation  Medanta The Medicity Hospital, Gurugram 
Address  Department of Liver Transplant and GI Anaesthesia, Medanta The Medicity Hospital, Gurugram 122001

Gurgaon
HARYANA
122001
India 
Phone  9902145542  
Fax    
Email  hanakoeshi07@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Eshita Singh 
Designation  Anaesthesiologist 
Affiliation  Medanta The Medicity Hospital, Gurugram 
Address  Department of Liver Transplant and GI Anaesthesia, Medanta The Medicity Hospital, Gurugram 122001

Gurgaon
HARYANA
122001
India 
Phone  9902145542  
Fax    
Email  hanakoeshi07@gmail.com  
 
Source of Monetary or Material Support  
Medanta The Medicity, CH Baktawar Singh Rd, Medicity, Islampur Colony, Sector 38, Gurugram, Haryana 122018 
 
Primary Sponsor  
Name  Dr Eshita Singh 
Address  Medanta The Medicity, CH Baktawar Singh Rd, Medicity, Islampur Colony, Sector 38, Gurugram, Haryana 122018 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr ESHITA SINGH  Medanta the Medicity Hospital  Medanta The Medicity, CH Baktawar Singh Rd, Medicity, Islampur Colony, Sector 38, Gurugram, Haryana 122018
Gurgaon
HARYANA 
09902145542

hanakoeshi07@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Medanta Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K74||Fibrosis and cirrhosis of liver, (2) ICD-10 Condition: K77||Liver disorders in diseases classified elsewhere,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Age of 18 years to 70 years of patients undergoing Right Lobe Living Donor Liver Transplant
 
 
ExclusionCriteria 
Details  Age less than 18 years
Age more than 70 years
Deceased Donor Liver Transplants
Combined Procedures (combined liver and cardiac bypass or combined liver and kidney transplant)
Retransplantations
Acute Liver Failure Patients 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To determine the Incidence and Predictors of Post Reperfusion Syndrome in Living Donor Liver Transplantation  1 Year 
 
Secondary Outcome  
Outcome  TimePoints 
Incidence of Early Allograft Dysfunction using Olthoff Criteria
Determine Early Allograft Dysfunction based on biopsy
Determine Acute Kidney Injury based on KDIGO criteria (Kidney disease : Improving global outcomes criteria)
Determine cardiac complications within first 7 postoperative days (arrhythmias, acute myocardial infarction, stroke, heart failure) as per Major Adverse Cardiac Events 
1 year 
 
Target Sample Size   Total Sample Size="163"
Sample Size from India="163" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   07/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Liver transplantation represents one of the most complex and resource-intensive surgical interventions in modern medicine, undertaken in patients with advanced liver disease and significant hemodynamic compromise. Despite improvements in surgical techniques, anesthesia, and perioperative care, intraoperative and early postoperative complications remain major determinants of graft and patient survival. Among these, Post Reperfusion Syndrome (PRS) and Early Allograft Dysfunction (EAD) are of particular concern, as they directly influence hemodynamic stability, graft viability, and long-term outcomes Post Reperfusion Syndrome (PRS) and Early Allograft Dysfunction (EAD), though temporally distinct, are mechanistically intertwined. The hemodynamic instability, ischemia-reperfusion injury, and metabolic insults characteristic of PRS can compromise graft function, creating a substrate for EAD in the postoperative period. Understanding their shared and independent risk factors, pathophysiology, and implications is essential for improving patient optimisation, intraoperative management, and postoperative care in liver transplantation. In this study we will be evaluating the contribution of PRS on the functioning of the graft in the postoperative period to correlate intraoperative PRS with postoperative EAD, helping identify modifiable risk factors to improve patient outcomes.

 
Close